Articles

Consolidative radiotherapy for residual FDG activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma

Department of Radiation Oncology, Mayo Clinic Jacksonville, FL
Department of Radiation Oncology, Mayo Clinic Rochester, MN
Department of Radiation Oncology, Mayo Clinic Rochester, MN
Department of Radiation Oncology, Mayo Clinic Phoenix, AZ
Department of Radiation Oncology, Mayo Clinic Rochester, MN
Division of Hematology and Medical Oncology, Mayo Clinic Phoenix, AZ
Division of Hematology and Medical Oncology, Mayo Clinic Phoenix, AZ
Division of Hematology, Mayo Clinic Rochester, MN, USA; Division of Experimental Pathology, Mayo Clinic Rochester, MN
Division of Hematology, Mayo Clinic Rochester, MN
Division of Hematology, Mayo Clinic Rochester, MN, USA; Department of Biostatistics, Mayo Clinic Rochester, MN
Division of Hematology, Mayo Clinic Rochester, MN
Division of Hematology, Mayo Clinic Rochester, MN
Division of Hematology, Mayo Clinic Rochester, MN
Division of Hematology, Mayo Clinic Rochester, MN
Division of Hematology, Mayo Clinic Rochester, MN
Division of Hematology, Mayo Clinic Rochester, MN
Division of Hematology and Medical Oncology, Mayo Clinic Jacksonville, FL
Division of Hematology and Medical Oncology, Mayo Clinic Jacksonville, FL
Division of Hematology and Medical Oncology, Mayo Clinic Jacksonville, FL
Division of Hematology and Medical Oncology, Mayo Clinic Jacksonville, FL
Department of Radiation Oncology, Mayo Clinic Jacksonville, FL
Department of Radiation Oncology, Mayo Clinic Jacksonville, FL
Haematologica Early view Jun 15, 2023 https://doi.org/10.3324/haematol.2023.283311